Cargando…
Immune-related gene risk score predicting the effect of immunotherapy and prognosis in bladder cancer patients
Background: Immune checkpoint inhibitor therapy has changed the treatment model of metastatic bladder cancer. However, only approximately 20% of patients benefit from this therapy, and robust biomarkers to predict the effect of immunotherapy are still lacking. In this study, we aimed to investigate...
Autores principales: | Zou, Yuantao, Yuan, Gangjun, Tan, Xingliang, Luo, Sihao, Yang, Cong, Tang, Yi, Wang, Yanjun, Yao, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577248/ https://www.ncbi.nlm.nih.gov/pubmed/36267410 http://dx.doi.org/10.3389/fgene.2022.1011390 |
Ejemplares similares
-
miR-138-5p-mediated HOXD11 promotes cell invasion and metastasis by activating the FN1/MMP2/MMP9 pathway and predicts poor prognosis in penile squamous cell carcinoma
por: Tan, Xingliang, et al.
Publicado: (2022) -
RAB20 Promotes Proliferation via G2/M Phase through the Chk1/cdc25c/cdc2-cyclinB1 Pathway in Penile Squamous Cell Carcinoma
por: Tan, Xingliang, et al.
Publicado: (2022) -
Identification of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with bladder cancer
por: Yao, Zhihao, et al.
Publicado: (2022) -
Immune Microenvironment Terms Signature Robustly Predicts the Prognosis and Immunotherapy Response in Bladder Cancer Based on Large Population Cohorts
por: Liang, Shengjie, et al.
Publicado: (2022) -
The Immune Cell Infiltration Patterns and Characterization Score in Bladder Cancer to Identify Prognosis
por: Zhang, Yongsheng, et al.
Publicado: (2022)